KELLY JARED enters ONCOLYTICS BIOTECH INC with 73.90K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2026ACC: 0001493152-26-000138
DirectorOfficer· Chief Executive Officer
Since Feb 2026
73.90K
Baseline shares
100% direct
73.90K
Direct ownership
1 position
3.65M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned73.90K
Total
73.90K direct73.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 73.90K | Direct |
| Total | 73.90K | 73.90K direct |
Derivative Holdings3
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
450K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
2.85M
Shares owned
N/A
Exercise price
0.57
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Shares
Underlying shares
350K
Shares owned
N/A
Exercise price
0.99
Expiration
—
Exercise window
—
Total
Underlying
3.65M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Shares | 1.08 | — | — | 450K | N/A |
| Stock Option Direct | Common Shares | 0.57 | — | — | 2.85M | N/A |
| Stock Option Direct | Common Shares | 0.99 | — | — | 350K | N/A |
| Total | 3.65M | 0.00 | ||||